MedTrace Logo

Incontinent Urinary Diversion Using an Autologous Neo-Urinary Conduit

NCT01087697 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 8

Last updated 2014-12-10

No results posted yet for this study

Summary

The purpose of this study is to see if the Neo-Urinary Conduit(NUC), which is made in the laboratory from a combination of a patient's own cells and other materials can be used to form a conduit to safety allow urine flow from the kidneys to outside the body after radical cystectomy in patients with bladder cancer.

Conditions

Interventions

DEVICE

Neo-Urinary Conduit

Implantation with the autologous Neo-Urinary Conduit

Sponsors & Collaborators

  • Tengion

    lead INDUSTRY

Principal Investigators

  • Gary Steinberg, MD · University of Chicago

  • Trinity J Bivalacqua, M.D., Ph.D. · The Johns Hopkins Medical Institute

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-03-31
Primary Completion
2014-12-31
Completion
2014-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01087697 on ClinicalTrials.gov